Selina Cox

Johns Hopkins University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index1.6kcitations40works2.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(15), Gastrointestinal motility and disorders(10), Digestive system and related health(9), Gut microbiota and health(5), Eosinophilic Esophagitis(5)

Publications40 total

120 Maximising clinical trial outputs: a UK experience implementing efficiency innovations
Journal of Investigative Dermatology·2025Open Access
P123 A novel self-referral enrolment pathway in a UK multicentre atopic dermatitis trial (BEACON trial): a single-site prospective observational study to assess feasibility and effectiveness
British Journal of Dermatology·2025Open Access
O12 Emulsifier restriction is an effective therapy for active crohn’s disease: the ADDapt trial – a multi-centre, randomised, double-blind, placebo-controlled trial
Oral Presentations·2025
P16 Emulsifier restriction does not impair nutrient intake and improves food-related quality of life in active crohn’s disease: the ADDapt trial
2025· 1 cited
796: A MULTI-CENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, RE-SUPPLEMENTATION TRIAL DEMONSTRATES THE EFFICACY OF A LOW EMULSIFIER DIET IN 154 PATIENTS WITH MILD TO MODERATELY ACTIVE CROHN’S DISEASE: THE ADDAPT TRIAL
Gastroenterology·2025· 2 cited
Patient and provider preferences for long-acting TB preventive therapy
IJTLD OPEN·2025· 2 citedOpen Access
DOP097 Emulsifier restriction is an effective therapy for active Crohn’s disease: the ADDapt trial - a multi-centre, randomised, double-blind, placebo-controlled, re-supplementation trial in 154 patients
Journal of Crohn s and Colitis·2025· 13 cited
P0757 Emulsifier restriction does not impair nutrient intake and improves food-related quality of life in active Crohn’s disease: dietary analysis of the ADDapt randomised controlled trial
Journal of Crohn s and Colitis·2025· 1 cited
Improving Food-Related Quality of Life in Inflammatory Bowel Disease through a Novel Web Resource: A Feasibility Randomised Controlled Trial
Nutrients·2022· 12 citedOpen Access
P415 Improving food-related quality of life in Inflammatory Bowel Disease with a novel web-based intervention: a randomised controlled feasibility trial
Journal of Crohn s and Colitis·2022· 1 citedOpen Access
Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing Aetiologies
Journal of Crohn s and Colitis·2021· 41 citedOpen Access
Food-additive emulsifiers: the worst thing since sliced bread?
˜The œLancet. Gastroenterology & hepatology·2021· 5 cited
Emulsifiers Impact Colonic Length in Mice and Emulsifier Restriction is Feasible in People with Crohn’s Disease
Nutrients·2020· 55 citedOpen Access
Challenges of the low FODMAP diet for managing irritable bowel syndrome and approaches to their minimisation and mitigation
Proceedings of The Nutrition Society·2020· 39 citedOpen Access
Food additive emulsifiers: a review of their role in foods, legislation and classifications, presence in food supply, dietary exposure, and safety assessment
Nutrition Reviews·2020· 149 cited
Food additive emulsifier restriction is feasible in people with Crohn's disease
Proceedings of The Nutrition Society·2020· 3 citedOpen Access
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial
Gastroenterology·2019· 352 citedOpen Access
Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease
Nutrients·2019· 718 citedOpen Access
Low fodmap diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria in quiescent inflammatory bowel disease
HAL (Le Centre pour la Communication Scientifique Directe)·2018
ADWE-09 Low fodmap diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria in quiescent inflammatory bowel disease
2018Open Access
page 1 of 2Next →

Frequent Co-authors

Kevin Whelan(20), James O. Lindsay(14), Peter M. Irving(10), Miranda Lomer(9), Alicia Sandall(9), Benoît Chassaing(6), Neil E. McCarthy(5), Nathalie Galleron(5), Florence Levenez(5), Aaron Bancil(5), Christos F. Kelaiditis(5), Yifan Xu(5), Megan Rossi(4), Sébastien Fromentin(4), Andrew J. Stagg(4), Megan Rossi(4), Leanne Smith(3), Hazel Clarke(3), Esther Peña(3), Sinead Burke(3)